Business● Low1h ago · Nov 5, 2026, 1:25 AM
Mckesson outlines fiscal 2027 adjusted EPS of $45.60-$46.40 while closing $2.25B Precision Medicine Group deal
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Mckesson has provided its fiscal 2027 adjusted earnings per share outlook, projecting between $45.60 and $46.40, alongside finalizing a $2.25 billion deal with Precision Medicine Group. This indicates the company's financial planning and strategic acquisitions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.